Searched for
BIOSECURE ACT IMPACT
In 1822, Europeans brought honey bees to Australia as agricultural heroes; 200 years later, researchers found they were helping tree death spread faster than windNew research published in NeoBiota suggests western honey bees may be helping spread myrtle rust, a destructive fungal disease threatening ...- Warburg-Mubadala team up, emerge as frontrunner for EncubeThe consortium is competing against EQT. Mumbai-based pharma co likely to be valued at $1.8 bn. Binding bids are scheduled for next week.
- Harvard spends nearly $1 million on lobbying under Trump administration over funding and student visasHarvard University significantly increased its federal lobbying to nearly $1 million in 2025, a two-decade high, to counter financial and r...
- Buy, Sell or Hold: Nuvama maintains reduce rating on Voltas; Morgan Stanley maintains equal weight on HCL TechnologiesBrokerages offer selective advice on large-cap stocks. Analysts weigh current challenges against future growth in sectors like pharma and I...
- Hospitals, CDMOs to lead pharma growth; generics face weak FY27, says JM Financial’s Amey ChalkeIndian healthcare is entering a new growth cycle, with hospitals and CDMO players expected to deliver strong 20% EBITDA CAGR, while large g...
- Ahead of Market: 10 things that will decide D-Street action on MondayOn Friday, the Indian market showed a bullish trend, with 171 stocks hitting their 52-week highs while 105 fell to 52-week lows. SBI and Et...
- Market Wrap: Sensex rises 329 points, Nifty tops 25,250 as financials rally on FPI comebackIndian benchmark indices Sensex and Nifty advanced Friday, lifted by gains in financial heavyweights on renewed foreign portfolio investor ...
- Pharma stocks slip up to 3% as uncertainties loom around Trump tariffsShares of Aurobindo Pharmaceuticals dropped 2% to a day's low of Rs 1,132.75, while Ipca Laboratories fell 2.7% to Rs 1,403.95. Sun Pharmac...
- FY27 may be a bit difficult for pharma companies due to US effect; betting on 2 stocks: Vishal ManchandaVishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs and weak US bu...
- Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino PathiparampilIndian pharma companies like Dr Reddy’s, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term. The generic Re...
- Investing in 2025: ICICIDirect's Pankaj Pandey betting on 4 big themes this yearWe are constructive on markets and believe the recent correction offers a good entry point to start accumulation for long term wealth gener...
- Which pharma companies will benefit from latest government policies? Sumit Gupta explainsThe Indian pharmaceutical sector is poised for growth, driven by government support for R&D and manufacturing. Policies promoting bulk drug...
- Sorbh Gupta continues to be bullish on consumer & pharma stocks. Here’s whySorbh Gupta, Senior Fund Manager at Bajaj Finserv AMC, expresses optimism about consumption trends and the pharmaceutical industry. He sees...
- Fund Manager Talk | Many smallcap stocks still in bubble zone, warns 360 ONE's Mayur PatelDespite recent correction, many smallcap stocks remain in bubble zone, lacking earnings growth support. Mayur Patel of 360 ONE Asset warns ...
- How will Biosecure Act impact Indian pharma companies? Aditya Khemka explainsWe own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on th...
- Doing nothing could be the riskiest thing of allThe cost of “doing nothing” in markets can indeed be substantial, but that pales in comparison to the cost of complacency when the margin o...
- Goldman picks 2 pharma stocks, screams sells on Laurus LabsGoldman Sachs' ratings triggered price movements, with Syngene and Neuland rising but Laurus falling. Syngene is set to benefit from China+...
- View: How to future-proof AI regulationThe Ministry of Electronics and Information Technology (MeitY) issued a revised AI advisory on March 15, overturning a provision from the M...
- View: Accelerate India-Myanmar economic ties with people at the centre stageWith shared people-to-people and geographic complementarities, India and Myanmar must galvanise a people-centric economic response to the p...
- Centre asks FAO to draw up norms for fisheriesThe Centre has urged Food and Agriculture Organisation (FAO) to formulate country specific approach for conducting risk analysis in aquacul...
Load More
